Vanda Pharmaceuticals IncVanda Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

Other companies in the scoring industry group for Vanda Pharmaceuticals Inc are displayed. The SDG rating for Vanda Pharmaceuticals Inc represents its transparency towards the UN SDGs. If you work at Vanda Pharmaceuticals Inc and you would like to use your ESG aseessment, please get in touch.

Vanda Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.3; made up of an environmental score of 2.0, social score of 1.6 and governance score of 3.2.

SDG Transparency Score for Vanda Pharmaceuticals Inc 

2.3

Low Impact
0 - 3
Medium
4 - 6
High
7 - 10
Last Score Update: 2024-05-01
What drives the score for Vanda Pharmaceuticals Inc 
2.0

Environmental

1.6

Social

3.2

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Caladrius Biosciences Inc
8.0
High
1Can Fite Biopharma Ltd
8.0
High
.........
1512Sol Gel Technologies Ltd
2.4
Medium
1512Windtree Therapeutics Inc
2.4
Medium
1529Vanda Pharmaceuticals Inc
2.3
Medium
1529ANI Pharmaceuticals Inc
2.3
Medium
1529Aarti Drugs Ltd
2.3
Medium
.........
1970Zyden Gentec Ltd
0.0
Low
1970iNtRON Biotechnology Inc
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Vanda Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Vanda Pharmaceuticals Inc disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Vanda Pharmaceuticals Inc report the average age of the workforce?

LockedSign up for free to unlock

Does Vanda Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Vanda Pharmaceuticals Inc disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Vanda Pharmaceuticals Inc disclose cybersecurity risks?

LockedSign up for free to unlock

Does Vanda Pharmaceuticals Inc offer flexible work?

LockedSign up for free to unlock

Does Vanda Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Vanda Pharmaceuticals Inc disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Vanda Pharmaceuticals Inc conduct supply chain audits?

LockedSign up for free to unlock

Does Vanda Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Vanda Pharmaceuticals Inc conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Vanda Pharmaceuticals Inc disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Vanda Pharmaceuticals Inc disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Vanda Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Vanda Pharmaceuticals Inc disclose water use targets?

LockedSign up for free to unlock

Does Vanda Pharmaceuticals Inc have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Vanda Pharmaceuticals Inc have a product recall in the last two years?

LockedSign up for free to unlock

Does Vanda Pharmaceuticals Inc disclose incidents of discrimination?

LockedSign up for free to unlock

Does Vanda Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Vanda Pharmaceuticals Inc issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Vanda Pharmaceuticals Inc disclose parental leave metrics?

LockedSign up for free to unlock

Does Vanda Pharmaceuticals Inc disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Vanda Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Vanda Pharmaceuticals Inc disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Vanda Pharmaceuticals Inc support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Vanda Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Vanda Pharmaceuticals Inc reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Vanda Pharmaceuticals Inc involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Vanda Pharmaceuticals Inc disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Vanda Pharmaceuticals Inc disclose its waste policy?

LockedSign up for free to unlock

Does Vanda Pharmaceuticals Inc report according to TCFD requirements?

LockedSign up for free to unlock

Does Vanda Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Vanda Pharmaceuticals Inc disclose energy use targets?

LockedSign up for free to unlock

Does Vanda Pharmaceuticals Inc disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Vanda Pharmaceuticals Inc have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Vanda Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.

Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under development include HETLIOZ (tasimelteon) for the treatment of jet lag disorder, smith-magenis syndrome, pediatric Non-24, autism spectrum, and delayed sleep phase disorder; Fanapt (iloperidone) for the treatment of bipolar disorder and a long acting injectable formulation program for the treatment of schizophrenia; and Tradipitant (VLY-686), a small molecule neurokinin-1 receptor (NK-1R) antagonist, for the treatment of atopic dermatitis, gastroparesis, and motion sickness. The company's products under development also comprise VTR-297, a small molecule histone deacetylase inhibitor for the treatment of hematologic malignancies and with potential use as a treatment for various oncology indications; VQW-765, a small molecule nicotinic acetylcholine receptor partial agonist for the treatment of psychiatric disorders; a portfolio of cystic fibrosis transmembrane conductance regulator activators and inhibitors for the treatment of dry eye and ocular inflammation, as well as BPO-27 for the treatment of secretory diarrhea disorders, including cholera; and VHX-896, the active metabolite of iloperidone. It markets its products in the United States, Europe, and Israel. Vanda Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in Washington, the District of Columbia.

Sorry!

Failed to process!